DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin ® Peanut Patch in 4“7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, &a

2 months ago 10

1. Homepage
2. Finance
3. DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin ® Peanut Patch in 4“7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, &a